Real-World Evidence for Health Equity in Prostate Cancer Awards
Prostate Cancer UK launched the Real-World Evidence for Health Equity in Prostate Cancer Awards to fund research that addresses disparities in prostate cancer outcomes, particularly among Black men and socioeconomically disadvantaged populations. This initiative supports projects that use real-world data (RWD) from NHS registries to uncover gaps and drive equitable healthcare policy and practice.
Eligibility Criteria
-
Research must focus on health inequities in prostate cancer, with emphasis on racial disparities, especially for Black men
-
Projects must use UK-based Real-World Data (RWD) collected outside clinical trials
-
Applicants should apply rigorous epidemiological methods with policy-changing potential
-
Studies may also consider factors such as socioeconomic status, geographic deprivation, and other social determinants of health
-
Collaboration with the Data & Evidence Team was encouraged prior to submission
Funding Details
-
Total budget: 1 million British Pounds
-
Expected to fund 4 to 6 projects
-
Applications were evaluated for impact, alignment with health equity goals, and value for money
Application Process
-
Full proposals submitted by May 27, 2025 at 1:00 p.m.
-
Proposals were reviewed by a multidisciplinary panel of scientific experts, health equity researchers, and patient/public representatives
-
Final decisions expected in August 2025
Where to Apply / Contact
-
Contact for inquiries: [email protected]
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023